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Background: The roles of genetic factors in human longevity would be better
understood if one can use more efficient methods in genetic analyses and investigate
pleiotropic effects of genetic variants on aging and health related traits.
Data and methods: We used EMMAX software with modified correction for population
stratification to perform genome wide association studies (GWAS) of female lifespan
from the original FHS cohort. The male data from the original FHS cohort and male and
female data combined from the offspring FHS cohort were used to confirm findings.
We evaluated pleiotropic effects of selected genetic variants as well as gene-smoking
interactions on health and aging related traits. Then we reviewed current knowledge on
functional properties of genes related to detected variants.
Results: The eight SNPs with genome-wide significant variants were negatively
associated with lifespan in both males and females. After additional QC, two of
these variants were selected for further analyses of their associations with major
diseases (cancer and CHD) and physiological aging changes. Gene-smoking interactions
contributed to these effects. Genes closest to detected variants appear to be involved
in similar biological processes and health disorders, as those found in other studies of
aging and longevity e.g., in cancer and neurodegeneration.
Conclusions: The impact of genes on longevity may involve trade-off-like effects on
different health traits. Genes that influence lifespan represent various molecular functions
but may be involved in similar biological processes and health disorders, which could
contribute to genetic heterogeneity of longevity and the lack of replication in genetic
association studies.
Keywords: longitudinal data, genetics of longevity, genetics of cancer, CVD, gene-environment interaction,
smoking and life span, aging changes
Introduction
The literature review on the genetic influence on human aging and longevity indicates limited
progress in identifying genetic mechanisms regulating human aging, health, and longevity using
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genome wide association studies (GWAS). Most associations
detected in these studies tend to be weak and have not reached
the genome-wide level of statistical significance. They also suffer
from the lack of replication in studies of independent popula-
tions. What factors and conditions might be responsible for such
a situation? What methods and approaches have to be used to
properly address these issues?
The literature on genetic studies of human longevity lacks an
appropriate biologically-based conceptual framework that would
allow one to efficiently address questions about the dynamic roles
of genes in forming aging and longevity related traits. Such a
framework would help specify necessary steps for efficient com-
prehensive analyses of corresponding genetic mechanisms using
available data. The approaches based on the systems biology of
aging, health, and longevity (Kriete, 2013; Yashin and Jazwinski,
2014) merged with biodemography of aging methods (Arbeev
et al., 2011; Yashin et al., 2012b) and statistical modeling (Yashin
et al., 2012a; Arbeev et al., 2014) have the potential to facilitate
progress in this direction.
The literature review also revealed the underutilized research
potential of available data that were used in genetic analyses of
aging and longevity traits. The possibility of more efficient anal-
yses of genetic associations with such traits was demonstrated
in Yashin et al. (1999, 2000) where the joint analyses of genetic
and demographic data in centenarians studies have been per-
formed. The methods of such analyses were further developed
and adjusted for the biological and biodemographic nature of the
traits and successfully used in data analyses (Yashin et al., 2007,
2013; Arbeev et al., 2011). The results of these analyses indicate
that the use of biodemographic ideas, models, andmethods could
shed more light on genetic mechanisms linking human aging,
health, and longevity.
In genetic analyses performed in this paper we used a mod-
ified statistical procedure of testing genetic associations with
longevity related traits. The populations whose data are used in
GWAS often have genetic structures called “population stratifi-
cation” (PS). Such structures are caused by non-random mating
between groups of individuals followed by different patterns of
genetic drift of allele frequencies in each group. Without proper
controlling for PS in the statistical procedures used in GWAS
of complex traits the analyses may result in erroneous (false-
positive) associations. To avoid such errors the genetic associ-
ation studies of complex traits include control for potential PS.
The method of principal components analyses (PCA) suggested
in Price et al. (2006) identifies several top principal compo-
nents (PCs) in genetic data and uses them as observed covari-
ates in the statistical estimation procedure in GWAS. Although
this approach may be efficient in GWAS of many complex traits
it may create problems in genetic association studies of human
longevity. This is because the process of mortality selection that
takes place in genetically heterogeneous cohorts may generate
additional genetic structures in the study populations. This struc-
ture which involves genetic variants affecting life span may be
captured by the selected principal components. As a result, con-
trolling for PS in GWAS of human aging and longevity may
reduce the estimates of associations of genetic variants with
longevity traits, i.e., it may substantially attenuate the signals
from the genetic variants one wants to detect. In this paper we
applied the new procedure for controlling for population strat-
ification (see Section S1 in Supplementary Materials) in GWAS
of human life span using data on females from the original
cohort of the Framingham Heart Study (FHS). This procedure
as well as the results of analyses using traditional and modi-
fied methods of controlling for potential PS in GWAS of human
longevity are described in Yashin et al. (2014). We investigated
the associations of the detected genetic variants with life span
in males from the original and in males and females from the
offspring FHS cohorts as well as with health related traits and
age trajectories of biomarkers from the original cohort. We also
investigated functional properties of genes related to detected
variants.
Data and Methods
In the discovery phase of the analyses we used the life span
data on genotyped females collected in the original cohort of
the Framingham Heart Study (FHS) (Giroux, 2013) as well as
genetic data. The genetic data were represented by 550,000 SNPs.
Genotyping was conducted using Affymetrix 500 K and 50 K
(non-overlapping) arrays. The lifespan data were available for
1529 participants from the original FHS cohort. The quality con-
trol (QC) procedure included 95% call rate for the sample and
95% call rate for SNPs, and HWE p-value > 1E-7. After apply-
ing the QC procedure, the data on 1111 individuals with infor-
mation about lifespan and 429,783 SNPs were available for the
analysis. Life spans for 204 study subjects (52 males and 152
females) were censored. We used EMMAX software to perform
GWAS of female lifespan data from the original FHS cohort with
modified correction for population stratification. In the confir-
mation phase we used genetic and the life span data on males
from the same FHS cohort and the life span data on males and
females combined from the offspring FHS cohort. Using available
data on cancer (all sites but skin) and CVD as well as longi-
tudinal data on physiological indices we estimated age trajecto-
ries of probabilities of staying free of the corresponding diseases
for carriers and non-carriers of selected genetic variants as well
as associations of these variants with age trajectories of physi-
ological indices. We also investigated how smoking modulates
estimated associations. More details about methods of data anal-
yses used in this paper are given in Section S1 of Supplementary
Materials.
Results
Genetic Variants Showing Association with Life
Span in Females are Replicated in Males
Discovery Phase
The most significant genetic variants (minor alleles) resulted
from GWAS on human life span using female data from the orig-
inal FHS cohort are shown in Table S1 (in Supplementary Mate-
rials) together with corresponding estimates of the effect sizes,
p-values, genetic frequencies, and other important characteristics
of these SNPs.
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Confirmation Phase
To test whether the selected genetic variants also show significant
associations with lifespan in males we performed genetic analysis
of the ten selected SNPs using lifespan data on 432 males from
the original FHS cohort. The same (additive) genetic model and
the same observed covariates were used in these analyses. The
results are summarized in Table S2 together with correspond-
ing estimates of the effect sizes, p-values, genetic frequencies, and
other important characteristics of these SNPs. This table shows
that the eight genetic variants that had negative associations with
lifespan in females also showed statistically significant negative
associations with lifespan in males.
Statistical estimates in Tables S1, S2 are obtained using mixed
effect regression model with imputed life span data on 204 study
subjects). It is unclear whether detected associations remain sta-
tistically significant when the methods free of life span imputa-
tion are used in the association analyses. To address this issue
we evaluated genetic associations of selected genetic variants with
mortality risk using Cox’s regression model that does not require
data imputation. The results of these analyses (Table S3) showed
highly significant associations between selected genetic variants
and mortality risks.
To test whether detected variants are associated with life spans
of themembers of the offspring FHS cohort we performed genetic
analyses of data for this cohort. Since the life span data for some
members of this cohort are censored these analyses have been
performed using the Cox’s regression model using gender as an
observed covariate. All selected variants showed significant asso-
ciations with mortality risk using data from the offspring cohort
(Table S7).
Empirical Survival Functions Estimated from
Longitudinal Data Confirm Detected
Associations
An important advantage of longitudinal data for genetic anal-
yses of lifespan is the opportunity to verify the research find-
ings obtaned using regression models in GWAS by constructing
and comparing empirical survival functions for carriers and non-
carriers of selected variants. Note that the case-control analysis,
typicaly used in genetic studies of centenarians, does not have
data to make such a verification. Since associations of the variants
with lifespan in our GWAS have the same direction of the effect in
both genders, the Kaplan–Meier estimates of conditional survival
functions for the genotyped members of the original FHS cohort
were evaluated for males and females combined. In such evalua-
tion we took into account that the life span data on the members
of the original FHS cohort are right censored and left truncated.
Note that for genetic analyses one should use age at blood collec-
tion (not the age at baseline) as the left truncation variable. We
calculated these variables using data from the DNA Draw Date
file available for FHS data from the dbGaP. Then we calculated
ages at death/censoring of those 1111 individuals using age at the
first exam and the number of days since the first exam until the
death event or censoring which are provided in the Framingham
data. Using these data and the R package “survival” we calcu-
lated Kaplan–Meier estimates of conditional survival functions
for carriers and non-carriers of selected genetic variants who
survived until specific ages (e.g., 70 or 80 years).
Figure 1 shows patterns of survival for carriers and non-
carriers of the minor allele, for two SNPs: rs7894051 (in ECHS1
gene), and rs4904670 (in NRDE2 gene) that were selected for
further analyses after additional QC procedure described in Sup-
plementary Materials.
Figures 1A,B show such functions conditional on survival to
age 70 years and the Figures 1C,D show these functions for those
who survived age 80 years (for males and females combined).
For rs7894051, the negative effect of the minor allele on survival
became pronounced only after age 80 years. The probabilities
of survival for carriers and non-carriers of these variants at the
age interval between 70 and 80 years are about the same. For
rs4904670, the negative effect on survival starts from the age 80.
This SNP manifests a survival trade-off, with minor allele having
positive effect on survival at ages before 80 and negative effect
afterwards. This illustrates the changing age-specific influence of
genes on vulnerability to death. The role of age as a modulator
of genetic effects on lifespan was suggested and discussed in our
prior works (De Benedictis et al., 1998; Yashin et al., 1999, 2000,
2001; Ukraintseva, 2005). Later, it was also noted in Atzmon et al.
(2006). Age-dependence of genetic effects on health and related
traits was also extensively discussed and analyzed in the past by
different research groups (e.g., Jarvik et al., 1997) including our
own (e.g., Kulminski et al., 2013). Note that the harmful influence
of the minor alleles on survival after the age 80 was manifested
for all eight genetic variants listed in Table S2. The Cox regression
analyses applied to the life span data from the original FHS cohort
showed that the difference in survival curves among minor allele
carriers and non-carriers for each of the eight SNPs, males and
females combined, was highly statistically significant (Table S3
Effects of gene-environment interaction on survival: the case of
smoking).
Using data on the smoking habit (ever or never) as well as
life span data on genotyped members of the original FHS cohort
(males and females combined) we evaluated effects of interac-
tions of detected genetic variants with the smoking habit on
survival. The results are shown in Figure 2.
Figures 2A,B show four survival functions for smoker-
carriers, smoker-non-carriers, non-smoker-carriers, and non-
smoker-non-carriers of the minor allele, for the two SNPs,
rs7894051 and rs4904670, introduced above. These figures show
that non-smokers-non-carriers have the best survival, while
smokers-carriers have the worst survival among all four groups.
This is an important illustration of gene-environment interaction
effects on survival, though one can see that the effect of genotype
is stronger than the effect of smoking in case of these two SNPs.
How do Detected Genetic Variants Influence
Incidence Rates of Cancer and CVD?
Using available data on ages at disease onset, we evaluated
conditional probabilities of staying free of cancer (all sites but
skin), for males and females combined who survived to 80 years
of age. The results for the two SNPs, rs7894051 and rs4904670,
are shown on Figure 3.
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FIGURE 1 | Kaplan–Meier estimates of conditional survival
functions for carriers/non-carriers of minor alleles of
rs7894051 (A,C) and rs4904670 (B,D) SNPs surviving to age 70
years (A,B) and age 80 years (C,D). Source: Framingham Heart
Study, original cohort, genotyped individuals after quality control,
females, and males combined.
One can see from this figure that when males and females
are combined, the rs7894051 does not influence cancer risk
(Figure 3A), while carrying the minor allele of rs4904670
(Figure 3B) increases that risk. The pattern observed in
Figure 3A may take place when the effect of this allele on can-
cer risk is opposite in males and females. To test this possibil-
ity, we evaluated the age patterns of probabilities of staying free
of cancer for males and females separately. The graphs shown
in Figures 3C,D provide evidence that such situation does take
place: the effects of minor alleles on cancer risk after age 80
were opposite in males and females for both rs7894051 and
rs4904670. That is, the presence of the minor allele in person’s
genome increased the risk of cancer in females and reduced it in
males for both the SNPs (Figures 3C–F). However, for rs4904670
the reduction of cancer risk in males did not fully compensate
for the increase in such risk in females, so that the total effect
of the minor allele of this SNP on cancer risk for males and
females combined was detrimental. The effects of rs7894051 and
rs4904670 on mortality rates from CVD and cancer are shown
in Tables S4, S5 in Supplementary Materials. The vulnerability
variants of these two SNPs increased the risk of CHD onset
after age 80 (Figures S2, S3 and Table S6). Since carrying the
vulnerability allele reduced the cancer risk in males at the same
ages, these results suggest potentially important role of antago-
nistic pleiotropic effects of genes in determining their impact on
longevity.
Longevity Related Variants can Modulate
Patterns of Aging Changes in Biomarkers
Using longitudinal data on body mass index (BMI) for genotyped
individuals from the original FHS cohort, we evaluated the aver-
age age trajectories of BMI for carriers and non-carriers of the
minor allele for the same two SNPs, rs7894051 and rs4904670, in
males and females. The results are shown in Figure 4.
One can see from Figures 4A,B that between ages 40 and
65 years the average values of BMI for carriers of minor alleles
exceeded those for non-carriers, in males and females combined.
After this age the curves intersected so that the BMI of the car-
riers became lower than that of the non-carriers. Figures 4C,D
show the effect of smoking habit on the average age trajecto-
ries of BMI for rs7894051 and rs4904670minor-allele carriers
and non-carriers. One can see that the average age trajectories
for non-smoker-carriers of the minor allele of any of the two
SNPs differed from other groups trajectories. It is also seen that
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FIGURE 2 | Kaplan–Meier estimates of survival functions for
smokers-carriers, non-smokers-carriers, smokers-non-carriers,
and non-smokers-non-carriers of the minor alleles of
rs7894051 (A) and rs4904670 (B) SNPs. Source: Framingham
Heart Study, original cohort, genotyped individuals after quality
control, females, and males combined.
smoking did not have a strong influence on the BMI age trajec-
tories for non-carriers, for any of the two SNPs. For rs7894051,
values of BMI for non-smoker-carriers were highest at the age
interval between 50 and 70 years. For rs4904670 the age trajec-
tory of BMI for the non-smoker-carriers sharply declined after
age 70, as for the rs7894051.
Genes Related to the Vulnerability Variants:
Biological Meaning
Table 1 shows essential characteristics and biological and health
effects of the two SNPs, rs7894051 and rs4904670 that passed
additional QC we applied as described in Supplement, as well
as related genes. We also included rs1794108 to this table and
relevant discussion because it is next top SNP by the size of
its effect on lifespan (though not by P-value), which could aid
biological interpretation of the findings. We conducted review
of current knowledge about biological and health effects of
these SNPs and related genes using up-to-date publications
and reliable online sources such as NCBI’s PubMed, Entrez
Gene, dbSNP, OMIM, Ensembl, GeneCards, GO, and Meta-
Core from Thomson Reuters. Genes related to SNPs identi-
fied in this study (or to SNPs that are in LD with them) are
largely involved in mitochondrial oxidation, apoptosis, and pro-
tein degradation in cell. These processes are important part
of cell/tissue responses to stress or damage. For example, the
NRDE2 (C14orf102) gene is linked to PSMC1, a subunit of 26S
proteasome involved in protein degradation, essential for cell
damage response. PSMC1may potentially interact with PSMD13,
which is another subunit of the same 26S proteasome involved
in protein degradation. ECHS1 is involved in mitochondrial oxi-
dation and apoptosis, also essential for cell/tissue response to
damage (Table 1).
On the level of health disorders, detected genes were most
often involved in cancer and neurological disorders, such as
schizophrenia and ASD, which broadly overlaps with biological
and health effects of genes found in other studies of aging and
longevity (e.g., Walter et al., 2011; Yashin et al., 2012c). The fre-
quent involvement of aging/longevity associated genes in neu-
rological disorders suggests an intriguing possibility that genes
predisposing to such disorders may accelerate brain physiologi-
cal aging, and through this negatively impact longevity (in addi-
tion to direct pathological effects). A number of recent studies
indicate that this might be the case, especially for schizophre-
nia (Kochunov et al., 2013; Koutsouleris et al., 2014; Shivakumar
et al., 2014; Wright et al., 2014; Silver and Bilker, 2015). Poten-
tial mechanisms by which the same genetic factor may influence
aging and brain pathology could involve, for example, declines in
regenerative response to damage, neural repair, axons outgrowth,
and synaptic transmission, typical of both brain aging and brain
disorders (Balu and Coyle, 2011; Edwards et al., 2011; Ferguson
and Son, 2011; Haroutunian et al., 2014).
As for connection between lifespan related genes and can-
cer, it appears to be complex and involve trade-offs. Our analy-
ses showed that carrying minor (vulnerability) allele of the two
selected SNPs increased cancer risk in females. For males, how-
ever, the effect of these variants on cancer was the opposite,
and carrying the vulnerability allele reduced the cancer risk in
males.
Since most centenarians avoid cancer (Andersen et al., 2005;
Joseph et al., 2014), it may seem logical that pro-longevity vari-
ants could indeed be among those protecting against cancer. Our
results for females are in line with this suggestion. However, vul-
nerability variants appear to be protective against cancer in males
in this study.
This raises another intriguing possibility that pro-longevity
variants (in non-carriers of vulnerability alleles) may some-
times do both, promote cancer and at the same time be poten-
tially against certain phenotypes of physical senescence. This
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FIGURE 3 | Effect of individual genetic variants on probability of
staying free of cancer of all sites but skin. The figure shows the
Kaplan–Meier estimates of conditional survival functions for individuals who
survived to age 80 years: carriers and non-carriers of the minor allele of
rs7894051, females and males (A), males (C), females (D) and carriers and
non-carriers of the minor allele of rs4904670, females and males (B), females
(E), males (F). Source: Framingham Heart Study, original cohort, genotyped
individuals after quality control.
could happen because cancer (all sites combined) and senescent
phenotypes such as physical frailty, and heart failure due to mus-
cle atrophy, have peakmanifestations at different ages: cancer risk
reaches its maximum typically before oldest old age (<85), while
senescence-related causes become major contributors to mor-
tality risk later (at ages 85+) (Ukraintseva and Yashin, 2003a,b;
Ukraintseva et al., 2008; Akushevich et al., 2012). If person who
carries such a genetic risk factor for cancer nevertheless survives
the period of the highest cancer risk (before age 85), s/he may get
an advantage from attenuated physical senescence at older ages,
so that such genetic variant may contribute to both longevity and
cancer (in case of our study, in males only). Since males and
females have markedly different body composition and physi-
cal manifestation of senescence, genetic factors could affect this
manifestation also differently, and be beneficial or deleterious in
only one gender.
Although biological and health effects of identified genes,
especially their involvement in damage response, and in cancer,
overlap with those earlier found in our and others’ studies of
aging and lifespan associated genes, the exact replication, such
as findings of identical SNPs or genes, is less common across
different studies.
Discussion
The process of population aging in the developed part of the
world has dramatic consequences for population health and
health-care financing, and makes the reduction of the disease
burden of the elderly people a high priority research problem.
Useful insights into possible strategies of improving the health
of the elderly could be produced from studying the roles of
genetic factors in connection with aging, health, and longevity.
An important implication of the results of such studies could
be the possibility of preventing many aging related chronic
diseases by slowing down or postponing individual aging pro-
cesses.
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FIGURE 4 | Average age trajectories of BMI for groups stratified
by smoking status and genetic background. The figure shows
the average age trajectories for carriers and non-carriers of the
minor alleles of rs7894051 (A) and rs4904670 (B) SNPs. (C,D)
show the average age trajectories of BMI for carriers and
non-carriers of the same SNPs with different smoking habits.
Positive Implications from Modest Progress of
GWAS of Human Life Span
The genetics of human aging and longevity became the subject
of intensive analyses during the last decade ranging from stud-
ies of candidate genes (Franceschi et al., 2000; De Benedictis
et al., 2001; Tan et al., 2001; Christensen et al., 2006; Christensen,
2008; Willcox et al., 2008) to genome-wide association studies
(GWAS) (Lunetta et al., 2007; Newman et al., 2010; Yashin et al.,
2010; Deelen et al., 2011, 2013; Nebel et al., 2011) that involved
hundreds-of-thousands to millions of SNPs. Although the results
of numerous GWAS of human aging and life span have modest
success and could not clearly describe factors and mechanisms
responsible for exceptional longevity, they have important posi-
tive implications. These results helped us identify problems that
need to be urgently addressed to have further progress in the
research field.Whyweremost of the detected genetic associations
with human life span so weak? Why was it so difficult to replicate
the research findings using data on independent studies? What
are the mechanisms by which genes influence life span? Can one
identify mechanisms that link lifespan-affecting genetic variants
with health indicators and aging-related changes in biomarkers?
How do detected variants interact with other genetic and non-
genetic factors to influence life span? To address these questions,
efficient approaches capable of studying the dynamic nature of
genetic effects on mortality and morbidity risks, as well as on
intermediate variables measured in longitudinal data have to be
used. The results obtained with the help of one such approach
were described in this paper.
Genetic Estimates in GWAS of Human Life Span
Require Proper Control for Population
Stratification
We applied a modified procedure for controlling for potential
population stratification in GWAS of human life span to detect
genetic variants strongly associated with life span in both males
and females and used longitudinal data to address questions
about the roles of these variants in health and survival outcomes,
age trajectories of biomarkers, as well as the effects of interac-
tions with non-genetic factors. Our aim was to make genetic
signals stronger, to evaluate genetic connections among aging-
related changes, health, and life span, to elucidate possible rea-
sons for the lack of replication, and to develop useful insights
into potential mechanisms of life span regulation. The GWAS
performed in these analyses used a modified procedure to con-
trol for possible population stratification. Such modification was
needed because the traditional procedure may interfere with the
process of mortality selection. The confirmation of the genome-
wide significant findings in a population of opposite sex (males)
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TABLE 1 | Essential characteristics of the two “vulnerability” SNPs (and their closest genes) associated with reduced lifespan in both sexes in the FHS
Original cohort.
SNP Ch Gene region Closest gene Gene/protein function in cell
and tissue
Physiological processes and
health disorders associated with
the gene/protein
rs7894051
*This SNP is in LD with
rs1049951, exonic
non-synonymous SNP in
the same gene
10q26.2 Intronic ECHS1—enoyl CoA
hydratase, short chain
1, mitoch.
ECHS1 catalyzes the hydration
of 2-trans-enoyl-coenzyme A
(CoA). Involved inmitochondrial
oxidation and apoptosis
suppression (Liu et al., 2010).
In LD with 3 intronic SNPs in
PAOX (oxidase) gene
Overexpressed in different cancers;
has been implicated in melanoma
(Lake et al., 2011), liver and colorectal
cancers (Xiao et al., 2013; Zhu et al.,
2013; Xie et al., 2014); suggested role
in neurological disorders
(Chiocchetti et al., 2014; Perluigi
et al., 2014)
rs4904670 14q32.11 Intronic NRDE2 (C14orf102)
necessary for RNA
interference, domain
containing
NRDE2 is highly expressed in the
brain (Maiti et al., 2011); linked to
PSMC1, proteasome 26S
subunit, ATPase, 1, involved in
protein degradation.
*The PSMC1 may potentially
interact with PSMD13, a gene
which is in LD with SIRT3 (see
below)
NRDE2 can be associated with
cancer (melanoma) (Chiu et al.,
2014); Suggested role of NRDE2 and
PSMC1 in schizophrenia (Maiti et al.,
2011); and in neurodegeneration
(Bedford et al., 2008)
rs1794108 11p15.5 Exon—nonsyn
coding
PSMD13—
proteasome 26S
subunit, non-ATPase,
13
PSMD13 is a proteasome
regulatory subunit, involved in
protein degradation. High LD
between PSMD13 and SIRT3.
*Sirtuins (SIRT1-7) play a central
role in epigenetic gene silencing,
DNA repair, cell-cycle,
microtubule organization, and
aging (Giblin et al., 2014)
Aging, longevity, cancer.
PSMD13-SIRT3 haplotype pools are
significantly different between
centenarians and younger people
(Bellizzi et al., 2007). Plays role in
stem cells aging and stress
response (Brown et al., 2013). SIRT3
can be a tumor promoter or tumor
suppressor, depending on context
(Alhazzazi et al., 2011)
Other SNPs are not shown because they did not pass additional QC that we applied as described in Supplement. The SNP rs1794108 was added to this table because it is next top
SNP, not by P-value but by the size of its effect on LS. It is also in LD with the SIRT3 gene. The minor allele of this SNP had negative effect on lifespan with significance in males (p <
1.65E-6) and in females (p < 1.91E-4).
in the same (original) cohort and in the offspring generation
indicates that these findings are likely to be true-positive. It also
indicates that GWAS of human longevity with inappropriate con-
trols for population stratification are likely to suffer from the low
level of statistical significance (weak signals) and from the lack of
replication.
Additional QC Testing
The genetic data from the original FHS cohort were one of the
first prepared for genetic analyses using GWAS, and a substan-
tial portion of genotyped cohort members died before the qual-
ity of genotyping was substantially improved. Therefore, these
data have higher chances of having genotyping error than more
recently produced datasets. Taking this into account we per-
formed testing of the quality of genotyping for eight genetic
variants detected in this study (Section S2 in Supplementary
Materials). As a result of this testing the two of these SNPs
rs7894051 (in ECHS1 gene), and rs4904670 (in NRDE2 gene)
were selected for further analyses of their associations with major
diseases (cancer and CHD) and physiological aging changes.
Thus, although detected genetic associations in eight SNPs were
confirmed twice (findings on female data were confirmed using
data on males from the original FHS cohort, and then using data
from the offspring FHS cohort), additional studies with higher
quality genetic data are needed to make final conclusions about
the involvement of all eight detected genes in regulation of health,
aging, and longevity related traits.
Benefits of Biodemographic Information for
Genetic Studies of Human Longevity
Researchers studying the genetics of human aging and longevity
tend to underestimate the role of demographic information in
genetic analyses of complex traits. Our analyses show that tak-
ing this information into account may substantially improve the
quality of genetic analyses. Indeed, researchers studying genet-
ics of human life span tacitly assume that population cohorts are
genetically heterogeneous with respect to individual susceptibil-
ity to death. The aging of individuals in heterogeneous cohorts
is accompanied by the process of mortality selection. The geneti-
cally vulnerable individuals tend to die first and genetically robust
members of the cohort will survive to the old and the oldest-
old ages. In Yashin et al. (1999, 2000, 2007, 2013) and Tan et al.
(2003), we developed and tested a series of statistical methods for
efficient joint analyses of genetic and demographic information
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in genetic studies of human longevity. The use of such methods
allowed us not only to improve estimates of associations between
genetic factors and longevity but also to evaluate and compare age
patterns of mortality rates for carriers and non-carriers of can-
didate alleles and genotypes. Such comparisons are not possible
using data on genetic frequencies alone.
Monotonic vs. Non-monotonic Age Patterns of
Allele Frequencies
Complex diseases, such as cancer, CVD, diabetes, and AD, are
major contributors tomortality in old age. Genetic variants which
increase risks of such diseases were shown to negatively affect
survival and/or be less common among the long-lived people in
many studies (e.g., Benes et al., 2001; De Benedictis et al., 2001;
Lescai et al., 2009; Park et al., 2009, 2010; Nebel et al., 2011; Ruiz
et al., 2011; Yashin and Jazwinski, 2014). The results of our analy-
ses are in line with negative effects of detected alleles on survival
after age 80 years. Note that such connection between genetic
variants and survival is manifested by monotonically declining
age patterns of the allele frequencies.
Previously we found that the non-monotonic age patterns of
allele frequencies are also possible (Yashin et al., 1999, 2000).
These patterns (e.g., when the variant’s frequency first declines,
then reachesminimum, and then increases) corresponds to a very
important property of some genetic variants where their effects
on mortality risk change with increasing age from detrimental to
beneficial. In this case the mortality curves for carriers and non-
carriers of the corresponding genetic variant intersect. Possible
reasons for such intersection are discussed in Yashin et al. (2001)
and Atzmon et al. (2006). Such a pattern could be responsible for
the seemingly paradoxical presence of “risk alleles” for complex
diseases in genomes of long-lived people, sometimes reported in
literature (e.g., De Benedictis et al., 1998; Bladbjerg et al., 1999;
Bonafe et al., 1999; Yashin et al., 1999, 2001b; Beekman et al.,
2010; Freudenberg-Hua et al., 2014). Thus, the results of genetic
studies of human longevity confirm the existence of two groups
of genetic variants which can be characterized by different age
patterns of genetic frequencies.
Genetic Heterogeneity of Complex Traits
The results of our analyses show that negative associations of
selected genetic variants with human life span in females were
confirmed inmales; they also influence the incidence rates of can-
cer of all sites combined (but skin) and CVD. One may argue
that the health and longevity traits investigated in this study (i.e.,
life span and two diseases) are too heterogeneous: individual dif-
ferences in life spans may depend on susceptibility to different
chronic conditions and cause specific mortality risks; cancers of
distinct sites are often associated with different genetic and non-
genetic factors; the term CVD includes many diseases dealing
with cardio-vascular problems, each having its own sets of risk
factors; etc. Although these concerns are certainly correct, one
often does not have much choice: the selection of a trait for anal-
ysis is determined by the available data which has to be enough to
get reliable conclusions from the analyses. Studying factors affect-
ing aggregated traits (e.g., cancer of all sites, all-cause, mortality
risk, etc.) may help us detect regularities and identify mecha-
nisms that are common for many specific phenotypes (cancers
of specific sites, mortality risks by cause, etc.) comprising such
traits. An important question is how best to analyze heteroge-
neous traits when you must? How can an understanding that the
trait is genetically heterogeneous affect methods and results of
analyses?
Despite the fact that the presence of such heterogeneity is
recognized by many researchers in the field, there is no agree-
ment concerning the best strategies for dealing with this issue.
The recommendation that follows from our experience would be
to investigate genetic heterogeneity by using different statistical
models of the connections between genetic factors and pheno-
typic traits, to consider how the results of analyses (e.g., sets of
selected genetic variants) differ for different quality control pro-
cedures, to perform careful studies of the non-replicating results,
keeping in mind that different genetic mechanisms may be respon-
sible for the same manifestation of a given trait. The goal of the
analyses thus becomes, not just finding the one or more longevity
(or vulnerability) alleles/genotypes responsible for the genetic
variation of life span in all individuals, but investigating possi-
ble alternative mechanisms responsible for developing this trait.
These mechanisms may involve different sets of genes in differ-
ent individuals or in different groups of individuals. The genetic
heterogeneity of longevity could be partly responsible for the lack
of replication of respective genetic association studies.
Genetic Mechanisms Linking Aging, Health, and
Longevity
Although exact replication, such as findings of identical SNPs or
genes, is not common across genetic association studies of aging
and longevity, biological and health effects of identified genes,
especially their involvement in similar damage responses, and in
similar pathology, often overlap between the different studies. In
our case, the involvement of selected genes (Table 1) in cancer
and neurological disorders was reported in both our and others’
studies of aging and lifespan associated genes (e.g., Walter et al.,
2011).
The results of our review of current knowledge also sug-
gest an intriguing possibility that the vulnerability SNPs in
genes involved in neurological disorders might also contribute
to accelerated brain aging, and through this negatively impact
longevity, which idea deserves further investigation. Con-
nections between lifespan related genes and cancer may
involve complex trade-offs. More detail on potential biologi-
cal mechanisms are provided in section on Biological Meaning
above.
In sum, our study demonstrated genetic connections among
lifespan, physiological aging changes, and complex diseases.
Comparison of functional properties of genes found in this and
other genetic studies of aging/longevity indicates that human
lifespan may be regulated by different sets of genes; however,
these genes tend to be involved in similar biological processes
and complex pathology. The fact that the same biological process
or health outcome may be realized through the different genes
suggests that genes may potentially be interchangeable in their
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influence on longevity. This could contribute to both genetic het-
erogeneity of longevity and to a lack of replication in genetic
association studies of lifespan and related phenotypes. Additional
studies with a higher quality genetic data are needed to support
our conclusions.
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